Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NGNE

Neurogene (NGNE)

Neurogene Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NGNE
DateTimeSourceHeadlineSymbolCompany
05/06/202421:30Business WireNeurogene to Participate in Upcoming ConferencesNASDAQ:NGNENeurogene Inc
03/06/202421:30Business WireNeurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot ProgramNASDAQ:NGNENeurogene Inc
10/05/202421:30Business WireNeurogene Reports First Quarter 2024 Financial Results and Highlights Recent UpdatesNASDAQ:NGNENeurogene Inc
07/05/202420:19Business WireNeurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual MeetingNASDAQ:NGNENeurogene Inc
23/04/202406:36Business WireNeurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT MeetingNASDAQ:NGNENeurogene Inc
19/03/202407:14Business WireNeurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent UpdatesNASDAQ:NGNENeurogene Inc
04/03/202423:30Business WireNeurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical TrialNASDAQ:NGNENeurogene Inc
29/02/202423:30Business WireNeurogene to Participate in Upcoming Investor ConferencesNASDAQ:NGNENeurogene Inc
16/01/202423:00Business WireNeurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical OfficerNASDAQ:NGNENeurogene Inc
05/01/202423:00Business WireNeurogene Announces Business Update and 2024 OutlookNASDAQ:NGNENeurogene Inc
 Showing the most relevant articles for your search:NASDAQ:NGNE